Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. (Q45115450)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

1 reference

1 reference

cytomegalovirus retinitis

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Georg Haerter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Burkhard J Manfras

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Yvonne de Jong-Hesse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Heike Wilts

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Peter Kern

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Michael Schmitt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

11 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

e88-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15494900%20AND%20SRC:MED&resulttype=core&format=json

Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy

4 January 2020

cites work

1 reference

Cytomegalovirus treatment options in immunocompromised patients

21 January 2018

1 reference

A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.

21 January 2018

1 reference

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

21 January 2018

1 reference

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

21 January 2018

1 reference

The tumor necrosis factor ligand and receptor families.

21 January 2018

1 reference

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

The divergent role of tumor necrosis factor receptors in infectious diseases

21 January 2018

1 reference

Role of cytokines in rheumatoid arthritis

21 January 2018

1 reference

New drugs for rheumatoid arthritis

21 January 2018

1 reference

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases

21 January 2018

1 reference

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

Experience with etanercept in an academic medical center: are infection rates increased?

21 January 2018

1 reference

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

21 January 2018

1 reference

The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression

21 January 2018

1 reference

Signal transduction by tumor necrosis factor and its relatives

21 January 2018

1 reference

Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis

21 January 2018

1 reference

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

21 January 2018

1 reference